AIM
JUNO

ARK Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

ARK Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-682,495
Closed -$31.2M – 208
2017
Q4 		$31.2M Buy
682,495
+161,380
+31% +$8.05M 2.48% 9
2017
Q3 		$23.4M Buy
521,115
+20,819
+4% +$710K 2.85% 9
2017
Q2 		$15M Buy
500,296
+252,029
+102% +$6.22M 2.91% 8
2017
Q1 		$5.51M Buy
248,267
+106,291
+75% +$2.28M 1.59% 24
2016
Q4 		$2.68M Buy
+141,976
New +$3.47M 0.97% 36

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

ARK Investment Management's JUNO Position: Q1 2018 in Review

ARK Investment Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 682,495 shares — an estimated $31.2M sold.

ARK Investment Management first reported a position in JUNO in Q4 2016 and held it in 5 quarters. The position peaked at $31.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • ARK Investment Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • ARK Investment Management sold 682,495 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $31.2M.
  • ARK Investment Management first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
  • ARK Investment Management's Juno Therapeutics, Inc. position peaked at $31.2M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on ARK Investment Management's 13F filing for Q1 2018, filed 14 May 2018.